Complications of COVID-19
Dr. Colleen Kraft, ASM President Elect, leads an in-depth discussion on how vaccination and therapeutics have been used to address the long-term complications of COVID-19. This free event is brought
Dr. Colleen Kraft, ASM President Elect, leads an in-depth discussion on how vaccination and therapeutics have been used to address the long-term complications of COVID-19. This free event is brought
The Roundtable on Genomics and Precision Health will host a virtual public workshop that will examine the current state of diversity (e.g., racial, ethnic) of the genetics and genomics workforce,
On October 5-6, 2021, the Forum on Neuroscience and Nervous System Disorders will host a virtual public workshop that brings together experts and key stakeholders from academia, industry, government, philanthropic
The COVID-19 pandemic has created unprecedented challenges for disaster planners and responders, bringing to light both shortfalls and opportunities. The rapid pace of operations and ongoing evolution of the public
This is the eighth virtual meeting of a consensus study focused on respiratory protection for the public and workers without respiratory protection programs. During the public portion of this meeting,
Hear from researchers and public health experts on present and future scenarios as they explore the changing landscape of the virus, including the Delta variant's impact on children, and the
In 1980 smallpox was declared eradicated after a global vaccination campaign. Today, only two labs in the world retain variola virus, the cause of smallpox, one in the USA and
Join faculty members from the Schar School’s Biodefense master’s program in a discussion on the future of global health security considering lessons learned from the COVID-19 pandemic. Policy Exchange: The
On Oct. 14 and 15, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet to discuss the use of booster doses of the Moderna COVID-19 Vaccine and